As of 2025-10-17, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (19.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.20 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -258.4%.
The range of the Relative Valuation is (17.78) - (20.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 19.0x |
| Forward P/E multiples | 17.6x - 22.1x | 19.4x |
| Fair Price | (17.78) - (20.75) | (19.33) |
| Upside | -245.7% - -270.1% | -258.4% |
| Date | P/E |
| 2025-10-16 | -12.09 |
| 2025-10-15 | -11.83 |
| 2025-10-14 | -11.13 |
| 2025-10-13 | -11.74 |
| 2025-10-10 | -11.67 |
| 2025-10-09 | -11.83 |
| 2025-10-08 | -11.80 |
| 2025-10-07 | -11.42 |
| 2025-10-06 | -10.87 |
| 2025-10-03 | -11.31 |
| 2025-10-02 | -10.96 |
| 2025-10-01 | -10.94 |
| 2025-09-30 | -11.58 |
| 2025-09-29 | -12.42 |
| 2025-09-26 | -12.42 |
| 2025-09-25 | -12.13 |
| 2025-09-24 | -12.45 |
| 2025-09-23 | -12.14 |
| 2025-09-22 | -12.09 |
| 2025-09-19 | -11.99 |
| 2025-09-18 | -12.59 |
| 2025-09-17 | -12.05 |
| 2025-09-16 | -12.32 |
| 2025-09-15 | -12.43 |
| 2025-09-12 | -12.69 |
| 2025-09-11 | -12.65 |
| 2025-09-10 | -12.93 |
| 2025-09-09 | -12.64 |
| 2025-09-08 | -12.59 |
| 2025-09-05 | -13.48 |
| 2025-09-04 | -12.58 |
| 2025-09-03 | -12.82 |
| 2025-09-02 | -12.58 |
| 2025-08-29 | -12.10 |
| 2025-08-28 | -12.41 |
| 2025-08-27 | -12.21 |
| 2025-08-26 | -12.21 |
| 2025-08-25 | -11.76 |
| 2025-08-22 | -12.19 |
| 2025-08-21 | -12.02 |
| 2025-08-20 | -11.85 |
| 2025-08-19 | -12.03 |
| 2025-08-18 | -12.20 |
| 2025-08-15 | -12.51 |
| 2025-08-14 | -12.54 |
| 2025-08-13 | -12.39 |
| 2025-08-12 | -12.36 |
| 2025-08-11 | -12.45 |
| 2025-08-08 | -12.10 |
| 2025-08-07 | -12.19 |